REFRESH OPTIVE GEL DROPS

Abbvie Corporation🇨🇦 Health Canada

Approval Id: dda06080c5169030
Drug Approval Canada Name: REFRESH OPTIVE GEL DROPS
Product Name: REFRESH OPTIVE GEL DROPS
Status: Marketed
Status Date: 2023-10-10
Original Market Date: 2017-07-28
Din: 02463652
Drug Class: Human
Dosage Form: Solution
Route Of Administration: Ophthalmic
Schedule: OTC
Ahfs: 52:13.00*
Atc Original: S01XA20 ARTIFICIAL TEARS AND OTHER INDIFFERENT PREPARATIONS.
Atc Name: s 01 xa 20
Aig Number: 0251696004
Company Name: Abbvie Corporation
Company Address: 8401 Trans-Canada Highway, Saint-Laurent, Quebec, Canada, H4S 1Z1
Company Detail Path: /organization/abbvie-corporation

CARBOXYMETHYLCELLULOSE SODIUM

1 % / W/V

GLYCERINE

0.9 % / W/V

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

dda06080c5169030

Type

Standard